|
Lissa Morgenthaler-Jones |
|
Lissa Morgenthaler-Jones Lissa Morgenthaler-Jones graduated from Princeton University with a degree in economics. She has followed technology stocks since 1981, working with First Boston and Woodman, Kirkpatrick and Gilbreath. She joined the California Technology Stock Letter as a Senior Analyst in 1985. CTSL was the #1 stock letter in the Hulbert Financial Digest ratings in 1987 and for the three-year period 1987-89, and was #2 for the ten years ended 1996. She has specialized in biotechnology investing since 1990 and been a venture capital limited partner since 1981. In 1998 she became portfolio manager of the Murphy New World Biotechnology Fund, which was #1 out of over 11,000 funds in spring 2000. Lissa last spoke for Informed Investors at the Seattle Cancer Conference and has written for such publications as Barron's and TheStreet.com. She's been quoted in The New York Times and BusinessWeek, has appeared on radio, CNBC and Wall $treet Week with Louis Rukeyser. Lissa now consults for Stanford Medical Center and is finishing her work on Arnold Schwarzenegger's Finance Committee.
Last update: 2/2/2004
|
_web.gif)
